The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
STRO · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | NEOG | ANGO | STRO | LH |
|---|---|---|---|---|
| Moat Score (0–100) | 40 (highest) | 40 (highest) | 40 (highest) | 39 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 60 (highest) | 31 | 60 (highest) | 38 |
| Pricing power | 80 | 89 (highest) | — | 43 |
| Returns on capital | 11 | 0 | 0 | 19 (highest) |
| Balance-sheet safety | 0 | 55 (highest) | 55 (highest) | 32 |
| Capital allocation | 48 | 24 | 44 | 65 (highest) |
| No price data | No price data | No price data | 111% above value if growth stopped today | |
| Market cap | $2.8B | $644M | $132M | $26.4B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2026 | FY2026 | FY2025 | FY2025 |